✦ LIBER ✦

Exon 20 PIK3CA mutations decreases survival in aggressive (HER-2 positive) breast carcinomas

✍ Scribed by Enrique Lerma; Lluis Catasus; Alberto Gallardo; Gloria Peiro; Carmen Alonso; Ignacio Aranda; Agusti Barnadas; Jaime Prat

Book ID: 106117991
Publisher: Springer
Year: 2008
Tongue: English
Weight: 246 KB
Volume: 453
Category: Article
ISSN: 1432-2307
DOI: 10.1007/s00428-008-0643-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcome impact of PIK3CA mutations in HE

Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab

✍ Cizkova, M; Dujaric, M-E; Lehmann-Che, J; Scott, V; Tembo, O; Asselain, B; Pierg 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 247 KB

PTEN, PIK3CA, p-AKT, and p-p70S6K Status

PTEN, PIK3CA, p-AKT, and p-p70S6K Status: Association with Trastuzumab Response and Survival in Patients with HER2-Positive Metastatic Breast Cancer

✍ Francisco J. Esteva; Hua Guo; Siyuan Zhang; Cesar Santa-Maria; Steven Stone; Jer 📂 Article 📅 2010 🏛 American Society for Investigative Pathology 🌐 English ⚖ 455 KB

The predictive role of phosphatase and t

The predictive role of phosphatase and tensin homolog (PTEN) loss, phosphoinositol-3 (PI3) kinase (PIK3CA) mutation, and PI3K pathway activation in sensitivity to trastuzumab in HER2-positive breast cancer: a meta-analysis

✍ Wang, Yaohui; Liu, Yu; Du, Yueyao; Yin, Wenjin; Lu, Jinsong 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 485 KB